دورية أكاديمية

Human cytomegalovirus seropositivity is associated with reduced patient survival during sepsis

التفاصيل البيبلوغرافية
العنوان: Human cytomegalovirus seropositivity is associated with reduced patient survival during sepsis
المؤلفون: Unterberg, Matthias, Ehrentraut, Stefan Felix, Bracht, Thilo, Wolf, Alexander, Haberl, Helge, Busch, Alexander von, Rump, Katharina, Ziehe, Dominik (Dr. rer. nat.), Bazzi, Maha, Thon, Patrick, Sitek, Barbara, Marcus-Alic, Katrin, Bayer, Malte, Schork, Karin (M. Sc.), Eisenacher, Martin, Ellger, Björn, Oswald, Daniel (Dr. med.), Wappler, Frank, Defosse, Jérôme (Dr. med.), Henzler, Dietrich, Köhler, Thomas, Zarbock, Alexander, Putensen, Christian, Schewe, Jens-Christian (Dr. med.), Frey, Ulrich, Anft, Moritz, Babel, Nina, Steinmann, Eike (Prof. Dr. rer. nat.), Brüggemann, Yannick, Trilling, Mirko, Schlüter, Andreas, Nowak, Hartmuth Sebastian Burkhard, Adamzik, Michael, Rahmel, Tim, Koos, Björn
سنة النشر: 2023
المجموعة: Dokumentenrepositorium der RUB / RUB-Repository (Ruhr-Universität Bochum)
مصطلحات موضوعية: Sepsis, ddc:610
الوصف: \(\bf Background\) Sepsis is one of the leading causes of death. Treatment attempts targeting the immune response regularly fail in clinical trials. As HCMV latency can modulate the immune response and changes the immune cell composition, we hypothesized that HCMV serostatus affects mortality in sepsis patients. \(\bf Methods\) We determined the HCMV serostatus (i.e., latency) of 410 prospectively enrolled patients of the multicenter SepsisDataNet.NRW study. Patients were recruited according to the SEPSIS-3 criteria and clinical data were recorded in an observational approach. We quantified 13 cytokines at Days 1, 4, and 8 after enrollment. Proteomics data were analyzed from the plasma samples of 171 patients. \(\bf Results\) The 30-day mortality was higher in HCMV-seropositive patients than in seronegative sepsis patients (38% vs. 25%, respectively; \(\it p\) = 0.008; HR, 1.656; 95% CI 1.135–2.417). This effect was observed independent of age (\(\it p\) = 0.010; HR, 1.673; 95% CI 1.131–2.477). The predictive value on the outcome of the increased concentrations of IL-6 was present only in the seropositive cohort (30-day mortality, 63% vs. 24%; HR 3.250; 95% CI 2.075–5.090; \(\it p\) < 0.001) with no significant differences in serum concentrations of IL-6 between the two groups. Procalcitonin and IL-10 exhibited the same behavior and were predictive of the outcome only in HCMV-seropositive patients. \(\bf Conclusion\) We suggest that the predictive value of inflammation-associated biomarkers should be re-evaluated with regard to the HCMV serostatus. Targeting HCMV latency might open a new approach to selecting suitable patients for individualized treatment in sepsis.
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: English
العلاقة: https://hss-opus.ub.ruhr-uni-bochum.de/opus4/frontdoor/index/index/docId/12531Test; urn:nbn:de:hbz:294-125314; https://nbn-resolving.org/urn:nbn:de:hbz:294-125314Test; https://hss-opus.ub.ruhr-uni-bochum.de/opus4/files/12531/KoosBj%C3%B6rn1.pdfTest
الإتاحة: https://hss-opus.ub.ruhr-uni-bochum.de/opus4/frontdoor/index/index/docId/12531Test
https://nbn-resolving.org/urn:nbn:de:hbz:294-125314Test
https://hss-opus.ub.ruhr-uni-bochum.de/opus4/files/12531/KoosBj%C3%B6rn1.pdfTest
حقوق: http://creativecommons.org/licenses/by/4.0Test/ ; info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.33132B2D
قاعدة البيانات: BASE